STOCK TITAN

Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Vanderbilt University Medical Center (VUMC) is implementing Masimo Radius VSM™ wireless vital signs monitoring system in its Emergency Department to address ER congestion. The pilot program enables continuous monitoring of patients in hallway beds, emergency service offload areas, and waiting rooms, where monitoring is typically periodic. The system, integrated with Patient SafetyNet™, allows clinicians to remotely monitor vital signs in real time from centralized stations, offering measurements including pulse oximetry, blood pressure, temperature, respiration rate, and ECG. The implementation aims to transform traditionally unmonitored spaces into areas of proactive patient care, potentially improving patient throughput and prioritization.

Il Vanderbilt University Medical Center (VUMC) sta implementando il sistema di monitoraggio wireless dei segni vitali Masimo Radius VSM™ nel suo Reparto di Emergenza per affrontare la congestione del pronto soccorso. Il programma pilota consente il monitoraggio continuo dei pazienti in letti situati nei corridoi, nelle aree di scarico dei servizi di emergenza e nelle sale d'attesa, dove il monitoraggio è tipicamente periodico. Il sistema, integrato con Patient SafetyNet™, consente ai clinici di monitorare i segni vitali in tempo reale da stazioni centralizzate, offrendo misurazioni tra cui la pulsoossimetria, la pressione sanguigna, la temperatura, il tasso di respirazione e l'ECG. L'implementazione mira a trasformare spazi tradizionalmente non monitorati in aree di cura proattiva del paziente, migliorando potenzialmente il flusso dei pazienti e la loro prioritizzazione.

El Centro Médico de la Universidad de Vanderbilt (VUMC) está implementando el sistema de monitoreo inalámbrico de signos vitales Masimo Radius VSM™ en su Departamento de Emergencias para abordar la congestión en la sala de emergencias. El programa piloto permite el monitoreo continuo de pacientes en camas en los pasillos, áreas de descarga de servicios de emergencia y salas de espera, donde el monitoreo es típicamente periódico. El sistema, integrado con Patient SafetyNet™, permite a los clínicos monitorear los signos vitales en tiempo real desde estaciones centralizadas, ofreciendo mediciones que incluyen oximetría de pulso, presión arterial, temperatura, frecuencia respiratoria y ECG. La implementación tiene como objetivo transformar espacios tradicionalmente no monitoreados en áreas de atención proactiva al paciente, mejorando potencialmente el flujo y la priorización de los pacientes.

밴더빌트 대학교 의료 센터(VUMC)는 응급실 혼잡 문제를 해결하기 위해 응급실에 Masimo Radius VSM™ 무선 생체 신호 모니터링 시스템을 구현하고 있습니다. 이 파일럿 프로그램은 통로에 있는 침대, 응급 서비스 이송 구역 및 대기실에서 환자를 지속적으로 모니터링할 수 있도록 하며, 이곳에서는 일반적으로 간헐적으로 모니터링이 이루어집니다. Patient SafetyNet™과 통합된 이 시스템은 의료진이 중앙 집중식 스테이션에서 실시간으로 생체 신호를 원격으로 모니터링할 수 있게 하며, 맥박 산소 측정, 혈압, 체온, 호흡수, 심전도 등의 측정 값을 제공합니다. 이 구현의 목표는 전통적으로 모니터링되지 않았던 공간을 적극적인 환자 치료 공간으로 전환하여 환자 흐름과 우선 순위를 개선하는 것입니다.

Le Centre Médical de l'Université Vanderbilt (VUMC) met en œuvre le système de surveillance sans fil des signes vitaux Masimo Radius VSM™ dans son Service d'Urgence pour faire face à la congestion des urgences. Le programme pilote permet la surveillance continue des patients dans les lits de couloir, les zones de transfert des services d'urgence et les salles d'attente, où la surveillance est généralement périodique. Le système, intégré avec Patient SafetyNet™, permet aux cliniciens de surveiller à distance les signes vitaux en temps réel depuis des stations centralisées, offrant des mesures comprenant la pulsoximétrie, la pression artérielle, la température, le taux de respiration et l'ECG. L'objectif de cette mise en œuvre est de transformer des espaces traditionnellement non surveillés en zones de soins proactifs pour les patients, améliorant potentiellement le flux des patients et leur priorisation.

Das Vanderbilt University Medical Center (VUMC) implementiert das drahtlose Vitalzeichen-Monitoringsystem Masimo Radius VSM™ in seiner Notaufnahme, um die Überlastung der Notaufnahme zu bekämpfen. Das Pilotprogramm ermöglicht die kontinuierliche Überwachung von Patienten in Flurbetten, Abholdiensten und Wartezimmern, wo die Überwachung normalerweise sporadisch erfolgt. Das System, das mit Patient SafetyNet™ integriert ist, ermöglicht es Ärzten, Vitalzeichen in Echtzeit von zentralen Stationen aus zu überwachen und Messungen wie Pulsoxymetrie, Blutdruck, Temperatur, Atemfrequenz und EKG anzubieten. Ziel der Implementierung ist es, traditionell nicht überwachte Bereiche in Zonen proaktiver Patientenversorgung zu verwandeln, was möglicherweise den Patientenfluss und die Priorisierung verbessert.

Positive
  • Implementation of wireless monitoring in previously unmonitored areas expands service capability
  • Potential for improved resource allocation and patient throughput
  • Successful pilot program paving way for expanded rollout
  • Technology enables real-time remote monitoring, potentially reducing response times
Negative
  • None.

Insights

The integration of Radius VSM at VUMC represents a significant advancement in emergency department operations and patient monitoring capabilities. This implementation addresses a critical pain point in healthcare delivery - ED congestion and patient monitoring in non-traditional spaces. The system's ability to provide continuous monitoring in waiting rooms and hallways fills a important gap in patient care where deterioration often goes unnoticed.

The technology's potential impact on resource utilization and patient throughput could translate to improved operational efficiency and reduced costs. For Masimo, this partnership with a prestigious institution like VUMC serves as a powerful reference case for future sales. The successful pilot program opens doors for expansion within VUMC and could accelerate adoption across other healthcare facilities, potentially driving significant revenue growth in Masimo's monitoring solutions segment.

The implementation addresses a critical operational challenge in emergency departments nationwide. By enabling continuous monitoring in non-traditional spaces, hospitals can optimize patient flow and resource allocation while maintaining safety standards. The real-time remote monitoring capability allows for more efficient staff deployment and faster response to patient deterioration.

The potential reduction in telemetry usage and improved patient throughput directly impacts the hospital's bottom line. For investors, this demonstrates Masimo's ability to deliver solutions that address both clinical and operational challenges, positioning them well in the competitive healthcare technology market. The scalability of the system and its potential application in other hospital departments suggests significant growth opportunities.

Renowned Healthcare Facility Launches Advanced Wireless Monitoring Technology in the Emergency Department, Reducing Wait Times and Improving Patient Prioritization

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of the Masimo Radius VSM™ patient-worn vital signs monitor with Masimo Patient SafetyNet™ supplemental remote monitoring in the Emergency Department (ED) and nontraditional care spaces. Launched as part of a successful pilot program aimed at tackling the ongoing crisis of emergency room congestion, Radius VSM has been used on hallway beds, in the emergency medical service offload area, and on patients in the waiting room who are typically only monitored periodically – thus providing continuous, wireless monitoring for those who may otherwise be left vulnerable to unexpected deterioration.

Masimo Radius VSM™ and Vanderbilt University Medical Center (Photo: Business Wire)

Masimo Radius VSM™ and Vanderbilt University Medical Center (Photo: Business Wire)

Radius VSM combines the reliability and accuracy of a bedside monitor with the comfort and freedom of a wearable device. With its implementation alongside Patient SafetyNet, clinicians at VUMC are able to remotely monitor vital signs in real time from centralized view stations, simplifying patient data management, enabling quicker intervention during possible deterioration, and enhancing patient safety—even while a patient is up and moving. The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET® pulse oximetry, measure-on-inflation noninvasive blood pressure, continuous temperature, respiration rate, and 3-leadwire electrocardiography (ECG).

By monitoring ED patients with Radius VSM, VUMC is transforming spaces that were traditionally devoid of continuous monitoring into areas of proactive patient care. This level of visibility may help clinicians reduce the use of telemetry, potentially saving time and resources and improving patient throughput and prioritization to other parts of the hospital, such as the general ward or medical and surgical wards. Additionally, Radius VSM’s innovative approach not only enhances the patient and clinician experience but exemplifies how cutting-edge technology can be seamlessly integrated into high-pressure settings like the ED to help streamline continuity of care.

The initial success of VUMC’s pilot program is paving the way for an expanded rollout within the ED designed to elevate care for vulnerable patients. Moreover, the promising results may lead to adoption in other areas of the hospital, such as medical and surgical wards, broadening the impact of Masimo’s innovative technology on patient care throughout VUMC. The program also underscores both Masimo’s and VUMC’s commitment to leveraging technology to rethink and improve patient care pathways, setting a new standard for how hospitals manage patient surges in the ED and beyond.

“Rising patient acuity and volume at VUMC necessitate strategic initiatives to augment our care infrastructure,” said Neal Patel, MD, MPH, Professor of Clinical Pediatrics and Chief Informatics Officer for HealthIT at VUMC. “Wireless physiologic monitoring in the ED enhances surveillance and vigilance of each patient’s status even when they are in the waiting room.”

Bilal Muhsin, Chief Operating Officer of Masimo, said, “We are excited to partner with Vanderbilt University Medical Center to bring Radius VSM to vulnerable patients in the emergency department, where continuous monitoring is not the norm. A core tenet of our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications—and one of the ways we achieve that is through continued innovation. With Radius VSM, clinicians have the power of cutting-edge technology in a modular, scalable design that’s both easy to use and comfortable for the patient. The applications are virtually limitless, and I cannot wait to see how the use of this technology is expanded to enhance patient safety not only in the emergency department, but across the continuum of care.”

@Masimo | #Masimo

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.1 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,2 improve CCHD screening in newborns,3 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.4-7 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,8 and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2024 Newsweek World’s Best Hospitals listing.9 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7®, Radius PPG®, and Radius VSM™, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97® and the Masimo W1® Medical Watch. Masimo hospital and home automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica®, Halo ION®, UniView®, UniView :60™, and Masimo SafetyNet®. Its growing portfolio of health and wellness solutions includes Radius Tº® and Masimo W1 Sport. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at www.masimo.com/evidence/featured-studies/feature/.

RPVi has not received FDA 510(k) clearance and is not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.

References

  1. Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on our website. Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
  2. Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
  3. de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
  4. Taenzer A et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287.
  5. Taenzer A et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
  6. McGrath S et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
  7. McGrath S et al. Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14 Mar.
  8. Estimate: Masimo data on file.
  9. https://www.newsweek.com/rankings/worlds-best-hospitals-2024/united-states

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo Radius VSM® and Masimo Patient SafetyNet™, as well as VUMC’s integration of such technologies in the ED and nontraditional care spaces. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo Radius VSM and Masimo Patient SafetyNet, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; risks related to our prediction that the initial success of VUMC’s pilot program will result in an expanded rollout within the ED and may lead to adoption in other areas of the hospital, broadening the impact of Masimo technology; risks related to COVID-19; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Media Contact:

Masimo

Evan Lamb

949-396-3376

elamb@masimo.com

Source: Masimo

FAQ

What is Masimo Radius VSM being used for at Vanderbilt University Medical Center?

Masimo Radius VSM is being used to provide continuous wireless vital signs monitoring in the Emergency Department, including hallway beds, emergency service offload areas, and waiting rooms, to combat ER congestion and improve patient monitoring.

What vital signs can Masimo (MASI) Radius VSM monitor?

The Radius VSM can monitor SET pulse oximetry, noninvasive blood pressure, continuous temperature, respiration rate, and 3-leadwire electrocardiography (ECG).

How does Masimo (MASI) Radius VSM improve emergency department operations?

It enables continuous monitoring in traditionally unmonitored areas, allows real-time remote monitoring from centralized stations, helps reduce telemetry usage, and improves patient throughput and prioritization.

Masimo Corporation

NASDAQ:MASI

MASI Rankings

MASI Latest News

MASI Stock Data

8.69B
49.16M
8.19%
94.87%
6.25%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
IRVINE